Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting
Go back to Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting| (NASDAQ: PVLA) | Delayed: 118.84 +5.74 (5.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $113.10 | 52 Week High | $ | |||
| Open | $115.29 | 52 Week Low | $ | |||
| Day High | $120.88 | P/E | N/A | |||
| Day Low | $114.55 | EPS | $ | |||
| Volume | 231,409 | |||||
